An AllTrials project

NCT03379662: A trial that was reported late by Erchonia Corporation

This trial has reported, although it was 455 days late in doing so.

Full data

Full entry on NCT03379662
Title A Double-blind, Placebo-controlled Randomized Evaluation of the Effect of the Erchonia® HLS Laser Device on Children and Adolescents With Autistic Disorder
Results Status Reported (late)
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date July 2, 2017
Completion date Oct. 28, 2017
Required reporting date Oct. 28, 2018, midnight
Actual reporting date Jan. 26, 2020
Date last checked at Nov. 30, 2021
Days late 455